Healios KK Stock

Healios KK Debt 2024

Healios KK Debt

1,332 JPY

Ticker

4593.T

ISIN

JP3835100003

WKN

A14U80

In 2024, Healios KK's total debt was 1,332 JPY, a 80.73% change from the 737 JPY total debt recorded in the previous year.

Healios KK Aktienanalyse

What does Healios KK do?

Healios KK is a Japanese company founded in 2011. It focuses on the development of neuroscience, particularly the treatment of central nervous system disorders. Healios KK is headquartered in Tokyo and currently employs approximately 100 employees. Business Model: Healios KK aims to develop and market innovative treatments for patients with neurological disorders. The company works closely with research institutes, universities, and other companies to make progress in the development of new drugs and therapies. Healios KK is also involved in clinical research and works to translate its research findings into new products. Divisions: The company focuses on four main areas: - Regenerative Medicine - Stem Cell Therapy - Brain-Computer Interfaces - AI-supported Diagnosis Regenerative Medicine: Healios KK researches new technologies for the treatment of neurological disorders through regenerative medicine, particularly through stem cell therapy. The company collaborates closely with researchers to develop groundbreaking technologies that support the healing of nerve cells and promote brain regeneration. Stem Cell Therapy: Healios KK also focuses on stem cell therapy, which is being investigated in the company's research labs to find new treatment options for patients with spinal injuries, strokes, Parkinson's, and other neurological disorders. Stem cell therapy involves using stem cells to regenerate damaged tissue in the brain or spinal cord. Brain-Computer Interfaces: Healios KK is also working on the development of brain-computer interfaces (BCIs) that aim to establish a direct connection between the brain and a computer. With the help of these interfaces, patients with paralysis or certain neurological disorders can regain control over their movements and activities. Healios KK has developed a smartglove that can be controlled using BCI. AI-supported Diagnosis: Using state-of-the-art artificial intelligence (AI) technologies, Healios KK is developing new and more effective diagnostic methods for neurological disorders. By developing algorithms based on brain scan images, AI-supported diagnoses are expected to be faster and more effective in the future. Products: Healios KK offers a wide range of products and therapies to effectively treat patients with neurological disorders. These include: - Stem Cell Therapy: The company develops and distributes stem cell therapies to treat patients with spinal injuries, strokes, and other neurological disorders. - Smartglove: Healios KK has developed an intelligent glove that is controlled through brain-computer interfaces. The glove is intended for patients who are unable to move their hands due to paralysis. - AI-supported Diagnosis: The company is working on computer-assisted diagnoses of neurological disorders that are more effective and accurate than conventional diagnoses. - Clinical Trials: Healios KK also conducts clinical trials to investigate the effectiveness of new therapies and treatment methods. Summary: Healios KK is a Japanese company focused on developing innovative therapies and treatment methods for neurological disorders. The company works closely with research institutes and other companies to make progress in the development of new drugs and therapies. Healios KK has four main divisions: Regenerative Medicine, Stem Cell Therapy, Brain-Computer Interfaces, and AI-supported Diagnosis. The company offers a variety of products, including stem cell therapy, smartgloves, and AI-supported diagnoses. Healios KK aims to enhance the lives of patients with neurological disorders by using innovative technologies to support their health. Healios KK ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Healios KK's Debt Structure

Healios KK's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Healios KK's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Healios KK’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Healios KK’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Healios KK stock

What is the debt of Healios KK this year?

Healios KK has a debt level of 1,332 JPY this year.

What was the debt of Healios KK compared to the previous year?

The debt of Healios KK has increased by 80.73% compared to the previous year increased.

What are the consequences of high debt for investors in Healios KK?

High debt can pose a risk for investors of Healios KK, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Healios KK?

Low debt means that Healios KK has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Healios KK affect the company?

An increase in debt of Healios KK can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Healios KK affect the company?

A reduction in debt of Healios KK can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Healios KK?

Some factors that can influence the debt of Healios KK include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Healios KK so important for investors?

The debts of Healios KK are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Healios KK take to change the debt?

To change the debt, Healios KK can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Healios KK pay?

Over the past 12 months, Healios KK paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Healios KK is expected to pay a dividend of 0 JPY.

What is the dividend yield of Healios KK?

The current dividend yield of Healios KK is .

When does Healios KK pay dividends?

Healios KK pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Healios KK?

Healios KK paid dividends every year for the past 0 years.

What is the dividend of Healios KK?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Healios KK located?

Healios KK is assigned to the 'Health' sector.

Wann musste ich die Aktien von Healios KK kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Healios KK from 8/15/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.

When did Healios KK pay the last dividend?

The last dividend was paid out on 8/15/2024.

What was the dividend of Healios KK in the year 2023?

In the year 2023, Healios KK distributed 0 JPY as dividends.

In which currency does Healios KK pay out the dividend?

The dividends of Healios KK are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Healios KK

Our stock analysis for Healios KK Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healios KK Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.